Access to medicines: making market forces serve the poor

Global Strategy and Plan of Action on Public Health, Innovation and Intellectual ... pharmaceutical industry is a business, and a big one. Multinational pharmaceutical companies, ... would stimulate efforts to get prices down through policies such as tiered pricing, voluntary and compulsory licensing, pooled procurement, and bulk purchasing. ...

  Pharmaceutical, Global, Policies, Pricing

NEW DRUG LISTING & PRICING POLICIES IN CHINA

pricing for “premium-priced” drugs, the majority of which are manufactured by multi-national companies (MNCs). For the first time, the Ministry has begun to consider pharmacoeconomic and budget-impact evidence in its decision-making, signaling the need for global companies to approach the Chinese market differently in future.

  Drug, Global, Chain, Policies, Listing, Pricing, New drug listing amp pricing policies in china

MEDICINES REIMBURSEMENT POLICIES IN EUROPE

authorities included in the Pharmaceutical Pricing and Reimbursement Information (PPRI) network, a literature review, qualitative interviews with authorities and researchers in selected case study countries, and a cross-country analysis of the actual financial burden for patients.

  Pharmaceutical, Policies, Reimbursement, Medicine, Europe, Pricing, Pharmaceutical pricing, Medicines reimbursement policies in europe

ESG Performance Summary 2020 - GSK

Public policies available online 32 In our Annual Report: Stakeholder engagement ... Pricing Improve the health of millions of people each year by making ... Pharmaceutical business revenue (£m) 17,276 17,269 17,554 17,056 Vaccines business revenue (£m) ...

  Performance, Pharmaceutical, Policies, Summary, 2200, Pricing, Esg performance summary 2020

Economic Survey 2021-22

160 Global Inflation 161 Domestic Inflation 162 Current Trends in Inflation and its Drivers 188 Housing Prices 193 Pharmaceutical Pricing 194 Long Term Perspective for Management of Supply Side Factors 6 Sustainable Development and Climate Change 197 India’s Progress on Sustainable Development Goals 203 State of the Environment

  Pharmaceutical, Global, Pricing, Pharmaceutical pricing

MARKET INSIGHT Biopharmaceutical CDMOs Analysis

The global biologics market is expected to account for ~30% of the entire pharma market by 2025 compared to 18.5% in 2015. In the ten year span from 2015 to 2025, the global biologics CDMO market is projected to grow at an average annual growth rate of 15.1% from $7.4b n to $30.3bn. 1

  Analysis, Global, Market, Insights, Biopharmaceutical, Dcom, Market insight biopharmaceutical cdmos analysis

EFFECTS OF INNOVATION TYPES ON FIRM PERFORMANCE - …

1 EFFECTS OF INNOVATION TYPES ON FIRM PERFORMANCE Gurhan GUNDAY a, Gunduz ULUSOY a,*, Kemal KILIC a, Lutfihak ALPKAN b a Sabanci University, Faculty of Engineering and Natural Sciences, 34956 Orhanli-Tuzla, Istanbul, Turkey b Gebze Institute of Technology, Department of Management, No:101 41400 Cayirova Gebze-Kocaeli, Turkey E-mail addresses: …